Nasus is a late bloomer in League of Legends. The champion can be one of the most powerful tanks in the game if players use him correctly. Gamers need to take a conservative approach in the first five ...
On September 28, 2022, League of Legends released a major number of changes for Nasus in its PBE (Public Beta Environment). It has been a while since Nasus received buffs within the game, but it looks ...
Number-fact #1: there are 116 champions in League of Legends today, and plenty more to come. Number-fact #2: there are 365 days in a year, and the character models in this four year old game look a ...
After Sivir, Rammus and Garen, Nasus, the Curator of the Sands, is the next champion to get a visual update and an Infernal skin as an addition. Riot continues visually updating old champions. Nasus, ...
Everyone hates Nasus at one point or other. Even Nasus players hate playing against Nasus. Why? Because he is pure, high-octane bullshit that can 1v5 your entire team if you let him just do his job.
On October 14, 2022, the fan-favorite Nasus support finally made its first appearance in League of Legends Worlds 2022 in the game between Rogue and DRX. Despite all the hype surrounding the champion, ...
Nasus Pharma has presented data from a pivotal trial of its opioid overdose treatment. The naloxone powder-based nasal spray was absorbed into the blood faster than Narcan, leading Nasus to detail ...
A League of Legends Worlds Prime Gaming emote is up for grabs each year, giving avid MOBA enthusiasts an all-new cosmetic to sass their enemies- I mean, show their emotions with. This year's emote ...
TipRanks on MSN
Nasus Pharma Issues Letter to Shareholders
Nasus Pharma (NSRX) issued a letter to its shareholders from its Chief Executive Officer, Dan Teleman. “Dear Shareholders, 2025 has been a ...
TipRanks on MSN
Nasus Pharma highlights transformational 2025 as NS002 intranasal epinephrine program advances and IPO completes
An announcement from Nasus Pharma Ltd. ( ($NSRX) ) is now available. On December 22, 2025, Nasus Pharma Ltd. released a shareholder letter from ...
TEL AVIV, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) (“Nasus Pharma” or the “Company”), a clinical-stage pharmaceutical company focused on the development of innovative ...
Dear Shareholders, 2025 has been a transformational year for Nasus Pharma. We’ve made considerable progress building a strong, focused company with significant clinical impact, by developing drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback